Market Place
Sourcing Support
GSK’s Trelegy Ellipta: US FDA Panel To Weigh Role Of Inhaled Corticosteroids
27 Aug 2020 //
PINKSHEET
GSK filing accepted by EMA for Trelegy Ellipta use in adult patients with asthma
27 Feb 2020 //
BUSINESSWIRE
Drugmakers from Pfizer to GSK to hike U.S. prices on over 200 drugs
01 Jan 2020 //
CNBC
GSK Submits Filing to FDA for Trelegy Ellipta Use in Patients With Asthma
03 Oct 2019 //
BUSINESSWIRE
FDA knocks back AstraZeneca`s respiratory ambitions
02 Oct 2019 //
BIOPHARMADIVE
AstraZeneca`s combo lung disease therapy fails to win FDA approval
02 Oct 2019 //
REUTERS
Phase III CAPTAIN Study of Trelegy Ellipta in Patients with Asthma
03 May 2019 //
BUSINESSWIRE
GSK chases Trelegy asthma nod with mixed phase 3 results
03 May 2019 //
FIERCE PHARMA
Ph III CAPTAIN Study of Trelegy Ellipta in Patients with Asthma Meets Primary
02 May 2019 //
BUSINESSWIRE
Teva closes in on $3B cost-cutting goal
02 May 2019 //
FIERCE PHARMA
GlaxoSmithKline expands API production for COPD inhalers
24 Oct 2018 //
FIERCE PHARMA
GSK submits regulatory application in Japan for once-daily single inhaler
29 May 2018 //
PRESS RELEASE
US clears paediatric use of GSK’s Arnuity Ellipta
22 May 2018 //
PHARMA TIMES
US FDA approves Trelegy Ellipta to treat patients with COPD
25 Apr 2018 //
PHARMABIZ
GSK reports Q1 sales decline
25 Apr 2018 //
PHARMA TIMES
GSK/Innoviva’s Trelegy Ellipta wins expanded nod for COPD
25 Apr 2018 //
PHARMA TIMES
Once-Daily Trelegy Ellipta Gains Expanded Indication in the US for the Treatment
24 Apr 2018 //
PRESS RELEASE
Landmark IMPACT study published in NEJM shows benefits of Trelegy Ellipta
19 Apr 2018 //
GSK
EU expands scope of GSK/Innoviva’s asthma inhaler
10 Mar 2018 //
PHARMA TIMES
Positive EU Approval for Labeling Update to GSK`s Relvar Ellipta
09 Mar 2018 //
DDDMAG
Theravance Shares Rise on Approval of Glaxo`s COPD Therapy
17 Nov 2017 //
NASDAQ
Europe approves GlaxoSmithKline`s new triple lung drug
17 Nov 2017 //
REUTERS
GSK, Innoviva’s Trelegy Ellipta cleared for COPD
17 Nov 2017 //
PHARMA TIMES
GSK`s three-in-one inhaler gets positive opinion from EU agency
15 Sep 2017 //
REUTERS
EMA committee recommends approval of once-daily single inhaler triple therapy
15 Sep 2017 //
PHARMABIZ
GSK and Propeller expand digital health collaboration
28 Aug 2017 //
BIOSPECTRUM
GSK seeks US FDA approval for Arnuity Ellipta to treat asthma in children
25 Jul 2017 //
PHARMABIZ
GSK files for extended use of Relvar Ellipta in asthma
24 Jul 2017 //
PHARMA TIMES
GSK’s inhaler improves asthma control in ‘real world’ study
09 May 2017 //
PHARMA TIMES
Propeller Health announces development agreement, R&D collaboration with GSK
01 Dec 2015 //
CPHI-ONLINE
GlaxoSmithKline to file application for COPD drug in Japan
24 Sep 2015 //
MARKET WATCH
GSK resumes production at plant where Legionella bacteria was detected
18 Aug 2015 //
FIERCE PHARMA MANUFACTURING
Prescription for Glaxo: A New Boss?
05 May 2015 //
BLOOMBERG BUSINESS
Japanese MHLW Approves GSK`s Encruse Ellipta For COPD Treatments
28 Mar 2015 //
PHARMABIZ
Thomson Reuters Names Most Promising Drugs of 2015
23 Mar 2015 //
THOMSON REUTERS
GSK, Theravance’s Breo Faces Scrutiny Over Safety for Asthma
17 Mar 2015 //
BLOOMBERG BUSINESS
